NCT05474586: To Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee |
|
|
| Completed | N/A | 236 | RoW | Collavant n2 40 mg/day, Glucosamine hydrochloride & Chondroitin sulfate, Microcrystalline cellulose | Vedic Lifesciences Pvt. Ltd. | Osteoarthritis, Knee | 07/23 | 07/23 | | |